Houlihan Lokey (HLI)
(Real Time Quote from BATS)
$159.75 USD
-2.23 (-1.38%)
Updated Sep 25, 2024 02:26 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for Houlihan Lokey, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 1,914 | 1,809 | 2,270 | 1,525 | 1,159 |
Cost Of Goods | 1,279 | 1,199 | 1,431 | 978 | 780 |
Gross Profit | 636 | 610 | 839 | 548 | 380 |
Selling & Adminstrative & Depr. & Amort Expenses | 273 | 269 | 226 | 140 | 150 |
Income After Depreciation & Amortization | 363 | 342 | 613 | 408 | 230 |
Non-Operating Income | 28 | -18 | -9 | 1 | 6 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 391 | 324 | 604 | 409 | 236 |
Income Taxes | 110 | 70 | 166 | 96 | 52 |
Minority Interest | 0 | 0 | 1 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 280 | 254 | 438 | 313 | 184 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 280 | 254 | 438 | 313 | 184 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 391 | 400 | 661 | 423 | 247 |
Depreciation & Amortization (Cash Flow) | 29 | 58 | 49 | 15 | 17 |
Income After Depreciation & Amortization | 363 | 342 | 613 | 408 | 230 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 68.16 | 67.59 | 68.26 | 68.67 | 65.73 |
Diluted EPS Before Non-Recurring Items | 4.49 | 4.54 | 7.10 | 4.62 | 3.20 |
Diluted Net EPS (GAAP) | 4.11 | 3.76 | 6.41 | 4.55 | 2.80 |
Fiscal Year end for Houlihan Lokey, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 513.61 | 520.46 | 511.13 | 466.99 | 415.83 |
Cost Of Goods | 348.63 | 347.33 | 341.36 | 310.69 | 279.50 |
Gross Profit | 164.98 | 173.13 | 169.77 | 156.30 | 136.33 |
SG&A, R&D, and Dept/Amort Expenses | 69.42 | 70.43 | 73.23 | 66.02 | 62.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | 95.56 | 102.70 | 96.54 | 90.28 | 73.35 |
Non-Operating Income | 4.31 | 15.34 | 6.04 | 3.30 | 3.01 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 99.87 | 118.04 | 102.58 | 93.57 | 76.35 |
Income Taxes | 10.93 | 36.96 | 31.77 | 26.54 | 14.96 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 88.94 | 81.08 | 70.80 | 67.03 | 61.39 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 88.94 | 81.08 | 70.80 | 67.03 | 61.39 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 68.50 | 68.49 | 67.89 | 67.87 | 68.00 |
Diluted EPS Before Non-Recurring Items | 1.22 | 1.27 | 1.22 | 1.11 | 0.89 |
Diluted Net EPS (GAAP) | 1.30 | 1.18 | 1.04 | 0.99 | 0.90 |